| Business Name: |
Cherry Pharmaceutical |
| Contact Person: |
Kathleen Czupich |
| Address: |
3805 Old Easton Road, Doylestown, Pennsylvania 18902 |
| Phone Number: |
(215) 589-6404 |
| Annual Revenue (USD): |
$50.000 to $99.999 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B (Business to Business) |
| Business Category: |
Research and Development Laboratories |
| SIC Code: |
8731 |
| NAICS Code: |
541712 |
| Share This Business: |
|
| Related Businesses: |
Gfree Bio LLC - Doylestown, PA 18902
Shar-X Biopharma LLC - Doylestown, PA 18902
Fox Chase Chem Diversity Center - Doylestown, PA 18902
Clinical Mobilty Technology - Doylestown, PA 18902
Alliance Discovery Inc - Doylestown, PA 18902
Serome Biosciences - Doylestown, PA 18902
Zasloff Laboratories - Doylestown, PA 18902
Toph Biologicals Inc - Doylestown, PA 18902
Alis Life Science LLC - Doylestown, PA 18902
Als Biopharma LLC - Doylestown, PA 18902
Captivate Pharmaceuticals - Doylestown, PA 18902
Jiffy Lid Technologies LLC - Doylestown, PA 18902
Pennsylvania Drug Discovery Institute - Doylestown, PA 18902
Jbs Science Inc - Doylestown, PA 18902
Pharmabridge Inc - Doylestown, PA 18902
Immunotope Diagnostics Inc - Doylestown, PA 18902
Enantigen Therapeutics Inc - Doylestown, PA 18902
|
The company Cherry Pharmaceutical provides B2B services in the form of Research and Development Laboratories from its single location in Pennsylvania.
1 to 4 employees work for Cherry Pharmaceutical, and the business now earns $50.000 to $99.999 per annum.
Cherry Pharmaceutical was launched in 0 and is classified under SIC code and category 8731 , and NAICS number and grouping 541712 .
To contact Cherry Pharmaceutical, please call Kathleen Czupich with the phone number (215) 589-6404 or visit its single location at 3805 Old Easton Road in Doylestown, Pennsylvania 18902.
The location of the single location can also be found using the coordinates .
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.